HARVARD BIOSCIENCE INC Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Harvard Bioscience Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2024.
  • Harvard Bioscience Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $311K, a 54.1% decline year-over-year.
  • Harvard Bioscience Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $883K, a 3.81% decline year-over-year.
  • Harvard Bioscience Inc annual Income Tax Expense (Benefit) for 2023 was $859K, a 155% increase from 2022.
  • Harvard Bioscience Inc annual Income Tax Expense (Benefit) for 2022 was $337K, a 128% increase from 2021.
  • Harvard Bioscience Inc annual Income Tax Expense (Benefit) for 2021 was $148K, a 71.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $883K $311K -$366K -54.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.25M -$353K +$765K +68.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $484K $210K -$375K -64.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $859K $715K -$59K -7.62% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $918K $677K +$1.96M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$1.04M -$1.12M -$2.1M -213% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.06M $585K +$723K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $337K $774K +$604K +355% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$267K -$1.29M -$1.5M -698% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $1.23M $986K +$1.21M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $25K -$138K -$123K -820% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 $148K $170K +$103K +154% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $45K $215K +$532K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$487K -$222K -$935K -131% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $448K -$15K -$70K -127% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $518K $67K +$519K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$1K -$317K -$263K -487% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $262K $713K +$1.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$1.34M $55K -$521K -90.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$815K -$452K +$2.81M +86.1% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$3.62M -$54K +$598K +91.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$4.22M -$885K -$516K -140% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$3.71M $576K -$29K -4.79% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$3.68M -$3.26M -$2.8M -603% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$880K -$652K -$633K -3332% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$247K -$369K -$254K -221% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 $7K $605K +$612K Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$605K -$464K -$796K -240% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $191K -$19K -$777K -103% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 $968K -$115K -$61K -113% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 $1.03M -$7K -$200K -104% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 $1.23M $332K -$16.5M -98% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $17.7M $758K +$1.01M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 $16.7M -$54K +$722K +93% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 $16M $193K +$556K Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 $15.4M $16.8M +$15.6M +1312% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$197K -$249K -$572K -177% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-17
Q2 2015 $375K -$776K -$1.02M -413% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-17
Q1 2015 $1.4M -$363K -$663K -221% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
Q4 2014 $2.06M $1.19M +$2.2M Oct 1, 2014 Dec 31, 2014 10-K 2016-04-29
Q3 2014 -$142K $323K +$218K +208% Jul 1, 2014 Sep 30, 2014 10-K 2016-04-29
Q2 2014 -$360K $248K -$73K -22.7% Apr 1, 2014 Jun 30, 2014 10-K 2016-04-29
Q1 2014 -$287K $300K +$1K +0.33% Jan 1, 2014 Mar 31, 2014 10-K 2016-04-29
Q4 2013 -$288K -$1.01M -$1.83M -224% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 $1.54M $105K -$173K -62.2% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 $1.72M $321K -$377K -54% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 $2.09M $299K -$306K -50.6% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 $2.4M $817K +$570K +231% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $1.83M $278K +$424K Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $1.4M $698K +$68K +10.8% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $1.34M $605K +$606K Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $730K $247K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$146K +$11M +98.7% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $630K +$15K +2.44% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$1K Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$11.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $615K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.